| 臺北醫學大學 |
2013 |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
|
Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang |
| 臺北醫學大學 |
2013 |
Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
|
Chen, CH;Huang, MC;Kao, CF;Lin, SK;Kao, PH;Chiu, CC;Lu, ML |
| 臺北醫學大學 |
2012 |
Combined Therapy with Thioridazine Decreases Plasma Levels of Quetiapine in Taiwanese Schizophrenic Patients
|
Chang, SC;Lu, ML;Wang, YC;Lin, FW;Huang, SH;Kuo, PH;Ho, HO;Wu, TH |
| 國家衛生研究院 |
2011-05 |
Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine
|
Chan, HW;Tsou, HH;Tian, JN;Lin, KM;Hsiao, MC;Shen, WW;Lu, ML;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Liu, SC;Chen, CY;Liu, YL |
| 國家衛生研究院 |
2010-04 |
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response
|
Tsai, MH;Lin, KM;Hsiao, MC;Shen, WW;Lu, ML;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Liu, SC;Chen, CY;Liu, YL |
| 國家衛生研究院 |
2009-10 |
Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan
|
Huang, MC;Lu, ML;Tsai, CJ;Chen, PY;Chiu, CC;Jian, DL;Lin, KM;Chen, CH |
| 國家衛生研究院 |
2009-10 |
Cytochrome P-450 Isozyme 2C19 Genetic Polymorphisms are Associated with Plasma Concentrations of Escitalopram
|
Tsai, MH;Lin, KM;Hsiao, MC;Shen, WW;Lu, ML;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Liu, SC;Liu, YL |
| 臺北醫學大學 |
2008 |
Metformin for Metabolic Dysregulation in Schizophrenic Patients Treated with Olanzapine.
|
吳姿樺; Chen CH; Chiu CC; Huang MC; Wu TH; Liu HC; Lu ML |
| 臺北醫學大學 |
2008 |
Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors
|
王莉萱; 吳姿樺; Wu TH; Chiu CC; Shen WW; Lin FW; Wang LH; Chen HY; Lu ML |
| 臺北醫學大學 |
2008 |
Aripiprazole resolves symptomatic hyperprolactinemia and sexual dysfunction in a male schizophrenic patient
|
陳俊興; Chen CH; Huang MC; Lu ML; |
| 臺北醫學大學 |
2008 |
Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient
|
盧孟良; Chen CH; Huang MC; Lu ML; |
| 臺北醫學大學 |
2008 |
Cabergoline-induced psychotic exacerbation in schizophrenic patients
|
陳俊興; 盧孟良; Chang CJ; Chen CH; Lu ML; |
| 臺北醫學大學 |
2008 |
Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine.
|
盧孟良; 陳俊興; Chen CH; Chiu CC; Huang HC; Wu TH; Liu HC; Lu ML |
| 臺北醫學大學 |
2008 |
Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors.
|
盧孟良; Wu TH; Chiu CC; Shen WW; Lin FW; Wang LH; Chen HY; Lu ML |
| 臺北醫學大學 |
2008 |
The biphasic changes of insulin secretion in schizophrenic patients treated with olanzapine
|
盧孟良; Lu ML; Chen CH; Liu HC; Chen PY; Yu SH; Chiu CC |
| 臺北醫學大學 |
2008 |
Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole
|
陳俊興; 盧孟良; Lu ML; Shen WW; Chen CH; |
| 臺北醫學大學 |
2008 |
Venlafaxine-Induced Excessive Yawning
|
盧孟良; 陳俊興; Chen CH; Lu ML |
| 臺北醫學大學 |
2007 |
Application of the Cockcroft-Gault method to estimate lithium dosage requirement
|
沈武典; 盧孟良; Chiu CC; Shen WW; Chen KP; Lu ML |
| 臺北醫學大學 |
2007 |
Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients
|
陳俊興; 盧孟良; Chen CH; Huang MC; Lu ML; |
| 臺北醫學大學 |
2007 |
Clinical treatment guideline for bipolar disorder worldwide
|
盧孟良; Lu ML |
| 臺北醫學大學 |
2007 |
Long-term psychological outcome of 1999 Taiwan earthquake survivors: a survey of a high-risk sample with property damage.
|
盧孟良; Chen CH; Tan HK; Liao LR; Chen HH; Chan CC; Cheng JJ; Chen CY; Wang TN; Lu ML |
| 臺北醫學大學 |
2007 |
The evaluation and prevention of metabolic syndrome among schizophrenic patients receiving antipsychotic treatment
|
盧孟良; Lu ML |
| 臺北醫學大學 |
2006 |
Metabolic effects of quetiapine and the modulation role of silymarin in schizophrenia patients.
|
吳姿樺; Huang SH; Lu ML; Wu TH; |
| 臺北醫學大學 |
2006 |
Metabolic effects of quetiapine and the modulation role of silymarin in schizophrenia patients.
|
吳姿樺; Huang SH; Lu ML; Wu TH; |
| 臺北醫學大學 |
2005 |
Screening postpartum depression with the Taiwanese version of the Edinburgh postnatal Depression Scale
|
許淳森; Teng HW; Hsu CS; Shih SM; Lu ML; Pan JJ; Shen WW |
